ARMPArmata Pharmaceuticals, Inc. Common Stock
CSNYSE American, LLC (XASE)·USD
Identity
- Security key
- 11901
- Ticker
- ARMP
- Type
- CS — Common Stock
- Exchange
- NYSE American, LLC(XASE)
- Venue group
- NYSE
- Operating MIC
- XNYS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 1994-05-27
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- ARMP
Detail
Enriched 2026-08-14 20:47
- Market cap
- $158,223,591.1
- Shares outstanding (class)
- 36,710,810
- Shares outstanding (weighted)
- 36,710,810
- SIC
- 2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
- Employees
- 61
- Location
- LOS ANGELES, CA
- Homepage
- https://www.armatapharma.com
- Description
Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.
Market cap and share counts drift.